Krystal Biotech, Inc. (KRYS): Price and Financial Metrics
KRYS Price/Volume Stats
| Current price | $164.83 | 52-week high | $219.34 |
| Prev. close | $160.83 | 52-week low | $107.50 |
| Day low | $159.20 | Volume | 898,300 |
| Day high | $165.98 | Avg. volume | 325,595 |
| 50-day MA | $179.82 | Dividend yield | N/A |
| 200-day MA | $179.52 | Market Cap | 4.74B |
KRYS Stock Price Chart Interactive Chart >
Krystal Biotech, Inc. (KRYS) Company Bio
Krystal Biotech Inc. develops and commercializes pharmaceutical products for patients suffering from dermatological diseases. The company’s lead product candidate includes KB103, which is in preclinical studies to treat dystrophic epidermolysis bullosa, a genetic disease. The company was founded in 2015 and is based in Pittsburgh, Pennsylvania.
KRYS Price Returns
| 1-mo | -9.58% |
| 3-mo | -10.50% |
| 6-mo | -7.53% |
| 1-year | 33.11% |
| 3-year | 130.60% |
| 5-year | 181.52% |
| YTD | 32.86% |
| 2023 | 56.60% |
| 2022 | 13.25% |
| 2021 | 16.58% |
| 2020 | 8.34% |
| 2019 | 166.51% |
Loading social stream, please wait...